Featured series 
Tag: Moses Judah Folkman
-
Health
M. Judah Folkman, biomedical pioneer, dies at 74
One of Harvard Medical School’s (HMS) most forward-looking and innovative physician-scientists, M. Judah Folkman, died suddenly Monday (Jan. 14) after suffering a heart attack at the Denver International Airport in Denver. He was 74. Folkman is widely known as a pioneer in the study of angiogenesis, the growth of new blood vessels. His findings in…
-
Health
Blood vessel drugs halt cancer growth
After decades of surviving peer rejection of his theory of cancer treatment by blocking tiny blood vessels, Judah Folkman has gone on to develop drugs that did what he predicted they would do. Folkman’s endostatin, the drug Fortune magazine called a failure, was used to treat 486 patients with lung cancer in China. At Dana-Farber…
-
Health
Many have ‘cancer,’ but few progress to true disease
Folkman and Kalluri suggest that most tumors don’t develop a blood supply that allows them to grow and progress to cancer, because people produce natural inhibitors of blood vessel growth, or angiogenesis. They write that a better understanding of these inhibitors may yield a new generation of nontoxic anticancer drugs that could be given preventively…
-
Health
Researchers explain how protein inhibits growth of blood vessels
Thirty years ago, Judah Folkman, of Children’s Hospital Boston and Harvard Medical School, first developed the idea that cancerous tumors are dependent on the growth of small blood vessels. Since then, Folkman and other researchers have sought a way to block the growth of cancer tumors through restricting or eliminating the small blood vessels that…